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Abstract
The productive human papillomavirus (HPV) life cycle is tightly linked to the differentiation
and cycling of keratinocytes. Deregulation of these processes and stimulation of cell pro-
liferation by the action of viral oncoproteins and host cell factors underlies HPV-mediated
carcinogenesis. Severe HPV infections characterize the wart, hypogammaglobulinemia,
infection, and myelokathexis (WHIM) immunodeficiency syndrome, which is caused by
gain-of-function mutations in the CXCR4 receptor for the CXCL12 chemokine, one of which
is CXCR41013. We investigated whether CXCR41013 interferes in the HPV18 life cycle in epi-
thelial organotypic cultures. Expression of CXCR41013 promoted stabilization of HPV onco-
proteins, thus disturbing cell cycle progression and proliferation at the expense of the
ordered expression of the viral genes required for virus production. Conversely, blocking
CXCR41013 function restored virus production and limited HPV-induced carcinogenesis.
Thus, CXCR4 and its potential activation by genetic alterations in the course of the carcino-
genic process can be considered as an important host factor for HPV carcinogenesis.
Author Summary
Human papillomaviruses (HPV) are epitheliotropic tumor viruses causing mostly benign
warts but that have developed strategies to establish persistent infections. Although host
immune responses clear most infections, persistence of some HPV types causes ~5% of
human cancers and severe pathogenesis in immunosuppressed individuals. How early
events in HPV infection, determined by the interaction between viral and host proteins,
might lead to viral persistence and pathogenesis is unknown. Here, we thought to investi-
gate this issue by providing mechanistic insights into the selective susceptibility to HPV
pathogenesis displayed by patients who are immunosuppressed as a consequence of
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mutations in the CXCR4 gene encoding for the receptor of the CXCL12 chemokine
(WHIM syndrome). We previously unraveled the existence of a general interplay between
the CXCL12/CXCR4 axis and HPV, which is hijacked toward cell transformation upon
expression of the CXCR4 mutant. Here, using three dimensional epithelial cell cultures to
analyze the HPV life cycle, we found that the CXCR4 mutant promotes cell hyperproli-
feration and stabilization of viral oncoprotein expression at the expense of virus produc-
tion. Our results, which identify CXCR4 as an important gatekeeper of keratinocyte
proliferation and as a new susceptibility factor in HPV pathogenesis, may be translated
into anti-viral and anti-cancer strategies.
Introduction
Human papillomaviruses (HPVs) are a family of highly related non-enveloped epitheliotropic
viruses that have co-evolved with their human host and developed powerful strategies to estab-
lish persistent infection [1]. Many reports have described HPVs as commensal viruses that can
persist on healthy skin [2–4]. HPVs selectively infect basal keratinocytes of stratified epithelia
and other discrete populations, including the cells located in the squamocolumnar junction of
the cervix [5, 6]. These viruses undergo productive replication strictly in the terminally differ-
entiated layers of the infected epithelium, and in most cases, cause no tissue damage or only
benign warts [7]. Although host immune responses resolve most infections, instauration of
persistent infections by the mucosal types of HPVs classified as high-risk, of which HPV16
and HPV18 are the most significant, is responsible for almost all cases of cervical carcinoma, a
leading cause of cancer death in women. These viruses are also responsible for most anal can-
cers, as well as a fraction of vulval, vaginal, penile, and oropharyngeal cancers, causing nearly
5% of human cancers worldwide [8]. Cutaneous high-risk HPV types that normally persist
without symptoms have also been associated with non-melanoma skin cancers in some rare
genetic diseases or in immunosuppressed patients [9, 10]. The oncogenicity of high-risk HPVs
appears in the context of asymptomatic persistent infections that can hinder host immune
responses as a result of evasion and subversion strategies [11]. In support of this idea, clinical
observations suggest that the frequency of HPV-associated cancers is increased in immuno-
suppressed patients [12, 13].
HPV-associated cancers are generally non-productive infections in which the viral E6 and
E7 oncoproteins are abnormally expressed. In contrast, the timing and induction of E6 and E7
expression are tightly controlled during productive HPV infection, as the infected cells migrate
towards the epithelial surface where the sequential appearance of the E4, L2, and L1 viral pro-
teins allows virus release [14]. Although HPV oncoproteins are primarily responsible for the
initiation and progression of cancer, only a small percentage of people infected with high-risk
HPVs develop cancers. This indicates a contribution for host factors in HPV malignancy,
although their mechanisms remain poorly understood [1].
One possible mechanism is that the changes in host cell signaling pathways that occur dur-
ing disease progression arise from deregulated E6/E7 oncoprotein expression, which increases
the risk of transformation [15]. HPV integration found in many HPV-positive carcinomas
predominantly results in deregulated oncoprotein expression. Integration has also been associ-
ated with several recurrent genomic alterations and the elevated expression of host cell genes
adjacent to the integration site [16]. Additionally, the oncoproteins of high-risk HPV types
have been proposed to induce genomic instability through subversion of the cellular functions
involved in DNA damage and repair responses [11, 17]. In addition, host factors might confer
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high susceptibility for the development of HPV-associated cancers, as cervical intraepithelial
neoplasias and cancers related to carcinogenic HPV infection have been linked to infection of
the cervical reserve cells [18] and/or the discrete population of cuboidal cells, which are located
in the cervical squamocolumnar junction and express a unique panel of genes [5, 19]. More-
over, severe HPV-associated pathogenesis (e.g. persistent verrucosis, dysplasia, neoplasia,
some cutaneous squamous cell cancers, and a high prevalence of genital cancer) is an underap-
preciated major manifestation of some primary immunodeficiencies and investigation of these
clinical developments has provided clues to the host risk factors involved [20].
The wart, hypogammaglobulinemia, infection, and myelokathexis (WHIM) syndrome is
associated with inherited gain-of-function mutations in the CXCR4 gene that encodes a recep-
tor for the CXCL12 chemokine [21]. Binding of CXCL12 to CXCR4 triggers typical activation
of Gαi protein-dependent pathways of a chemokine receptor that are regulated in a timely
manner by β-arrestins, which preclude further G protein activation (i.e., desensitization) and
also link CXCR4 to additional signaling pathways involved in cytoskeleton reorganization and
anti-apoptotic signaling [22, 23]. In WHIM, the CXCL12/CXCR4 signaling pathways manifest
by abnormally increased and prolonged G protein- and β-arrestin-dependent responses asso-
ciated with an impaired desensitization of CXCR4. Such dysfunction are responsible for the
characteristic panleukopenia [24] in WHIM patients and likely also account for the severity of
HPV disease through mechanisms that involve target cells and systemic immunity. From an
immunological perspective, the unprecedented remission of HPV-induced warts in a WHIM
patient after spontaneous partial inactivation of CXCR4 and subsequent restoration of
immune function [25] suggests a role for myeloid cells in HPV life-cycle in support of the
anomalies observed in WHIM patients’ myeloid cells [26]. However, whether it indicates that
myeloid cells participate to host defense against HPV or, that they contribute to HPV-induced
disease, when altered in WHIM patients, as reported in instances of chronic inflammation
[27], remains unknown. Evidence for the involvement of the CXCL12/CXCR4 pair in the
HPV life cycle arose from the abnormal and specific expression of CXCL12 observed in kerati-
nocytes of HPV-productive skin or mucosal lesions regardless of whether patients suffer from
WHIM [28]. Expression levels of CXCL12 and its receptors, which increase in keratinocytes as
a consequence of HPV genome expression, generate an autocrine signaling loop essential for
keratinocyte proliferation and migration. This interplay is involved in the WHIM-associated
gain-of-function CXCR4 mutant, which confers transforming capacity on HPV18-immorta-
lized keratinocytes in mice [29]. This further supports the hypothesis that dysfunction of the
CXCL12/CXCR4 signaling pathway contribute to the pathogenesis of HPV-associated cancer.
However, the mechanism accounting for this process and whether it affects viral replication
is not known. Here, we investigated a possible role for the WHIM-associated gain-of-function
mutant receptor CXCR41013 in the HPV life cycle using HPV18 in the context of three-dimen-
sional organotypic raft cultures of keratinocytes, the sole replicative model for HPV [30]. Our
data indicate that the CXCR41013 mutant receptor shifts the HPV18 life cycle toward carcino-
genesis, which is reflected in a viral gene expression pattern that favors oncoprotein stabiliza-
tion. Blockade of either the CXCL12/CXCR4 axis or downstream effectors restored the
productive HPV life cycle. Thus a main finding is that the WHIM-associated mutant CXCR4
receptor has a keratinocyte-intrinsic effect on HPV life cycle, supporting the idea that not all
the effects of this mutation are mediated through dysregulation of the immune system.
Besides, our results demonstrate an important function for the CXCL12/CXCR4 axis in the
control of keratinocyte proliferation and its role in triggering transformation by HPV upon
signaling imbalances resulting from cell hyperproliferation and elevated levels of oncoprotein-
induced signaling.
The CXCL12/CXCR4 Pathway in HPV Pathogenesis
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Results
CXCR41013 alters the productive HPV life cycle
Expression of CXCR41013 but not the wild-type CXCR4 receptor (CXCR4wt) confers primary
human keratinocytes immortalized by HPV18 with transforming capacity, such that they
develop solid tumors in nude mice [29]. We therefore explored a role for CXCR41013 in the
HPV vegetative cycle in experimental models. As HPV properly replicates only within strati-
fied epithelium, we set up three-dimensional organotypic cultures (raft cultures) that form der-
mal and epidermal layers resembling those in skin. These cultures support the productive
HPV life cycle because the infected epithelial cells differentiate during their migration towards
the epithelial surface. We used spontaneously immortalized human keratinocytes (NIKS cells)
that grow normally, and can undergo terminal differentiation when cultured in rafts [31]. In
NIKS cells the expression levels of ectopically expressed wt and mutant CXCR4 receptors
(CXCR4wt or CXCR41013) were in the same range at the RNA and protein levels (S1 Fig, panels
A, B and C). Viral genome copy numbers were similar among the various NIKS cells in mono-
layer (i.e. expressing the endogenous CXCR4wt solely or with either CXCR4wt or CXCR41013
ectopically expressed receptors) and were increased in the same range upon differentiation of
NIKS cells in organotypic cultures (S2 Fig, panel A). Viral transcript levels (E6E7 and E2) were
also similar in NIKS cells expressing the exogenous wt or mutant forms of the receptor (S2 Fig,
panel B). The global architectures and subcellular topologies of raft cultures expressing
CXCR41013 or CXCR4wt (CXCR41013- or CXCR4wt-rafts) was apparently unchanged within
CXCR41013-expressing raft cultures (Fig 1, panel A) as well as the expression pattern of
CXCR4 receptors (endogenous CXCR4 and ectopically expressed wt and mutant forms) in
basal and supra-basal layers (S1 Fig, panel D). CXCR41013- and CXCR4wt-rafts also exhibited
normal expression patterns for keratin 10 in the spinous and granular layers, and the keratin
filament-associated filaggrin protein in the granular layer, which are two prominent markers
of epidermal differentiation (Fig 1, panels B-C). In contrast, replication of the viral genome
was strongly diminished in CXCR41013-raft cultures compared to that in CXCR4wt-rafts (Fig 2,
panel A). Consistent with its role in HPV replication [32], production of the E2 viral protein
was also lower in CXCR41013-raft cultures (Fig 2, panel B). Production of viral proteins
involved in the completion of the HPV life cycle in the upper epithelial layers, were also dra-
matically reduced (L1) or nearly undetectable (E4) in CXCR41013-rafts compared to their levels
in CXCR4wt-rafts (Fig 2, panels C-D). The E4 expression pattern in native NIKS raft cultures
expressing endogenous CXCR4 (S3 Fig) was comparable to that observed in CXCR4wt-raft cul-
tures (Fig 2, panel C), further supporting the relevance of the CXCR4wt-raft model. We have
then searched for the biosynthesis of infectious viral particles, which is the final step in the
HPV life cycle. We found that CXCR4wt-rafts are producing virions, which were infectious in
an HaCaT cell infection assay as detected by the presence of the HPV spliced E1E4 transcript
[33], while the CXCR41013-rafts did not contain detectable infectious virions (S4 Fig). These
data were correlated with the presence of koilocytic cells in the intermediate layers of the
CXCR4wt-rafts (e.g. Fig 1, panels A-B). Collectively, the dramatic lowest production of E2, L1,
and E4 proteins in CXCR41013-rafts together with the absence of any detectable infectious viri-
ons strongly suggest that this cell environment restricts replication and the productive HPV
life cycle.
CXCR41013 promotes oncogene expression
To gain further insight into the consequences of CXCR41013 expression on HPV life cycle, we
analyzed expression of the E6 and E7 viral oncogenes and their surrogate markers. Western
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blot analyses of raft cultures showed that E6 and E7 protein production in CXCR41013-rafts
was significantly higher than in CXCR4wt-rafts (Fig 3, panel A and control experiments for
antibodies specificity in S5 Fig). Since we were unable to detect E7 and E6 proteins in raft cul-
tures by immunohistochemistry because of high background, we used surrogate markers to
investigate the expression of these proteins. E7 is known to disrupt proteins involved in cell
cycle progression, resulting in substantial induction of a functionally inactive form of cyclin-
dependent kinase inhibitor 2A (p16), which can be used as an indicator of deregulated
E7-expression and HPV-associated dysplastic and neoplastic lesions [9]. The minichromo-
some maintenance (MCM) family of cell cycle proteins are essential for eukaryotic DNA repli-
cation, and MCM7 and MCM2 are widely used as molecular surrogates of E6/E7 expression
and E6/E7-mediated cell cycle entry [34]. In agreement with this, MCM2 and p16 expression
levels were higher in CXCR41013-rafts than in CXCR4wt-rafts. Compared to the limited distri-
bution of p16 staining in basal layers, MCM2 staining was more widespread and intense, and
extended into the upper epithelial layers (Fig 3, panels B-C-D). The significantly higher levels
of oncogene expression observed in CXCR41013-rafts, were not paralleled by neither higher
E6/E7 transcript levels nor changes in E2 transcripts levels (S6 Fig, panel A). This was consis-
tent with our inability to detect any HPV genome integration (S6 Fig, panel B) or enhanced
transcriptional activity of the HPV long control region (LCR) (S6 Fig, panel C) in CXCR41013-
rafts.
To determine whether the E6 and E7 oncoproteins were stabilized in CXCR41013 cells, we
quantified E6 and E7 protein levels over time in CXCR4wt- and CXCR41013-expressing kerati-
nocytes induced to differentiate in medium containing a high concentration of calcium. This
model permits the activation of late events and the productive phase of the HPV life cycle after
48−96 h of culture [35]. In NIKS cells differentiated for 96 h in high-calcium medium, E6 and
Fig 1. Expression of CXCR41013 does not modify the architecture of raft cultures or the differentiation
program of keratinocytes. (A) Representative HPV18-positive CXCR4wt and CXCR41013 raft culture
sections stained with hematoxylin, eosin, and safran (HES) (A) or stained for keratin 10 (B) or filaggrin (C).
Images are representative of three independent experiments. Scale bars = 100 μm.
doi:10.1371/journal.ppat.1006039.g001
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E7 protein decay after 2 h of cycloheximide treatment was lower in CXCR41013 keratinocytes
than in CXCR4wt keratinocytes, resulting in higher relative levels of E6 and E7 in CXCR41013
keratinocytes (S7 Fig, panel A). In contrast, in undifferentiated NIKS cells we observed no sig-
nificant difference in the stability of oncogenes (S7 Fig, panel B). These results suggest that the
viral oncoproteins were stabilized in the presence of CXCR41013 in differentiated cells.
HPV life cycle deregulation is associated with early markers of
carcinogenesis
An elevated proliferation rate is an early step in viral oncogenesis [8]. The Ki-67 antigen,
which is expressed in all phases of the cell cycle except in G0, is widely used to assess
Fig 2. Abortive HPV18 infection in rafts cultures expressing CXCR41013. Images of HPV18-positive CXCR4wt and
CXCR41013 raft culture sections depicting HPV DNA by in situ hybridization (A) and HPV18-E2 (B), HPV18-E4 (C), and HPV18-L1
(D) by immunohistochemical staining. Quantifications of HPV DNA-, E2-, E4- and L1-positive cells from histological analyses are
expressed as the percentage of positive cells out of the total number of epithelial cells. Values are means ± SEM. **p < 0.01,
***p < 0.001. Images are representative of three independent experiments. Scale bars = 100 μm, inset scale bar = 10 μm.
doi:10.1371/journal.ppat.1006039.g002
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Fig 3. Expression of HPV oncoproteins and their surrogate markers is enhanced in CXCR41013 rafts. (A)
Western blots (left) and densitometric analyses (right) showing relative levels of HPV18-E6 and HPV18-E7
expression in HPV18-positive CXCR4wt and CXCR41013 rafts. E6 and E7 protein levels were normalized to GAPDH
The CXCL12/CXCR4 Pathway in HPV Pathogenesis
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proliferation and represents a biomarker for cervical cancer [34]. Immunohistochemical anal-
yses of Ki-67 in raft cultures indicated higher levels of cellular proliferation in the basal and
suprabasal compartments of CXCR41013 rafts than in those of CXCR4wt rafts, and a higher
overall proportion of (Ki-67-positive) cells in cycle (Fig 4 panels A, C). Keratinocyte prolifera-
tion is normally restricted to the basal layers in CXCR41013-rafts in the absence of HPV infec-
tion (S8 Fig), indicating that CXCR41013 does not deregulate cell proliferation on its own but
rather acts synergistically with HPV. Given the capacity of E6 to promote degradation of the
p53 protein, a gatekeeper of aberrant cell cycle progression involved in cell cycle arrest and
apoptosis [36], we quantified apoptotic cell numbers in raft sections by TUNEL assay and p53
protein levels by western blot (Fig 4). There were fewer TUNEL-positive apoptotic cells in sec-
tions of CXCR41013 rafts than in CXCR4wt rafts suggesting that the overall proportion of apo-
ptotic cells can significantly lower in CXCR41013 rafts (Fig 4, panels B-C). Consistent with
these results, p53 levels were significantly lower in CXCR41013-rafts than in CXCR4wt rafts (Fig
4, panel D). These results demonstrate that CXCR41013 plays an important role in driving the
HPV18 viral life cycle toward carcinogenesis, notably by increasing the levels of the HPV
oncoproteins.
Inhibition of the ATM DNA damage pathway in CXCR41013-expressing
rafts
HPV, like other viruses associated with human cancers, was recently shown to hijack DNA
damage response pathways responsible for maintaining genomic integrity. Proteins involved
in these pathways include the ataxia telangiectasia mutated (ATM) and Rad3-related protein
kinases, as well as p53 and the CHK1 and CHK2 kinases, which are involved in downstream
checkpoint pathways [17]. Activation of the ATM/CHK pathway in the course of HPV infec-
tion provides a suitable environment for viral replication in differentiated cells [37]. The
mechanisms of this activation, which may be part of the HPV replication process itself, are not
completely understood but may involve the E1, E2, and E7 proteins [38]. To investigate
whether the ATM/CHK pathway can be differentially modified in a CXCR41013-expressing
background as a result of altered viral replication or higher E7 expression levels, we analyzed
the expression of the ATM and CHK proteins in keratinocytes differentiated in high-calcium
medium. Progression of normal differentiation was indicated by increases in involucrin pro-
tein abundance over time in CXCR41013- and CXCR4wt-expressing NIKS cells cultured in
high-calcium medium (Fig 5, panel A). In differentiated HPV18-positive NIKS cells, E6 pro-
tein levels were higher in cells expressing CXCR41013 than in those expressing CXCR4wt (Fig 5,
panel B). These results confirmed and extended our findings in raft cultures (Fig 3). Confirm-
ing our results in raft cultures (Fig 4), p53 protein levels at 96 h were lower in CXCR41013-
expressing cells than in CXCR4wt-expressing cells (Fig 5, panel A), which was likely related to
the higher levels of E6 protein in CXCR41013-expressing cells. The expression patterns of ATM
and its activated phosphorylated form (pATM) in control cultures (Fig 5, panel C, CXCR4wt-
cells) were concordant with previous report [37]. After 96 h of culture, pATM levels were
lower in CXCR41013-expressing cells than in CXCR4wt-expressing cells (Fig 5, panel C).
Accordingly, the levels of the activated phosphorylated form of CHK2 (pCHK2) kinase were
protein levels and arbitrarily set at 1 for CXCR4wt rafts (staining controls are shown in S5 Fig). Values are
means ± SEM. **p < 0.01. HPV18-positive CXCR4wt and CXCR41013 raft sections stained for p16 expression by
immunohistochemistry (B) and for MCM2 expression by immunofluorescence (C). Detection of MCM2 expression by
western blot (D). MCM2 protein levels were normalized to GAPDH protein levels and arbitrarily set at 1 for CXCR4wt
rafts. Means ± SEM are shown. ***p < 0.001. Images are representative of three independent experiments. Scale
bars = 100 μm.
doi:10.1371/journal.ppat.1006039.g003
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significantly lower in keratinocytes expressing CXCR41013 than in those expressing CXCR4wt
at 96 h but also at 48 h (Fig 5, panel C). This correlates with the tendency of CXCR41013-
expressing cells to have lower levels of activated ATM. Altogether these results suggest that the
presence of CXCR41013 might lead to suboptimal activation of the ATM pathway and a
reduced ability to support HPV replication.
Normalizing β-arrestin-dependent signaling partially restored the
productive HPV life cycle
The suboptimal HPV replication environment in keratinocytes expressing CXCR41013
prompted us to examine the consequences of normalizing the CXCR41013-enhanced signaling.
One of the key pathways accounting for the CXCR41013 gain-of-function is the enhanced β-
Fig 4. CXCR41013 expression in raft cultures promotes keratinocyte proliferation and reduces apoptosis. (A) Detection of Ki-67
expression by immunohistochemical staining in proliferating HPV18-positive CXCR4wt and CXCR41013 raft culture sections. (B) Apoptotic cells
(green) in HPV18-positive CXCR4wt and CXCR41013 rafts identified by TUNEL assay. Nuclei (blue) were counterstained with DAPI. Images are
representative of three independent experiments. Scale bars = 100 μm. (C) Quantification of Ki-67-positive and apoptotic cells from the
histological analyses. Results are expressed as the percentage of positive cells out of the total number of epithelial cells. Values are
means ± SEM. ***p < 0.001. (D) Western blots (left) and densitometric analyses (right) showing relative levels of p53 in HPV18-positive
CXCR4wt and CXCR41013 rafts. p53 protein levels were normalized to GAPDH protein levels and arbitrarily set at 1 for CXCR4wt rafts. Values
are means ± SEM. ***p < 0.001.
doi:10.1371/journal.ppat.1006039.g004
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arrestin-mediated signaling, which is dependent upon the third intracellular loop (SHSK
motif) of CXCR4 [39], which is also required for mobilization of intracellular calcium and G-
protein-independent stimulation of JAK2/STAT3 in response to CXCL12 [40]. Therefore, we
expressed CXCR41013 lacking the SHSK motif, CXCR41013&ΔSHSK in keratinocyte raft cultures
(Fig 6). In leukocytes, CXCR41013&ΔSHSK exhibited normal β-arrestin–mediated signaling and
CXCL12-induced chemotaxis [39]. In raft cultures expressing CXCR41013&ΔSHSK, E2 protein
levels were significantly higher than in CXCR41013-rafts (Fig 6, panel A). E4 and L1 proteins
were detected in the upper epithelial layers of the CXCR41013&ΔSHSK-rafts (Fig 6, panels B-C).
Proliferating cells expressing the Ki-67 antigen remained confined to basal and suprabasal lay-
ers (Fig 6, panel D), as in CXCR4wt raft (Fig 4, panel A). Thus, CXCR41013&ΔSHSK, with normal
Fig 5. Inhibition of the ATM DNA damage pathway in CXCR41013-expressing rafts. Western blots and densitometric analyses showing
relative levels of involucrin and p53 (A), HPV18-E6 (B), pATM, ATM, pCHK2 and CHK2 (C) in HPV18-positive CXCR4wt and CXCR41013 NIKS
cells differentiated in high calcium media (Ca) for indicated times. Levels of target proteins were normalized to GAPDH protein levels and
arbitrarily set at 1 for undifferentiated (Ca 0 h) CXCR4wt NIKS cells. Values are means ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
doi:10.1371/journal.ppat.1006039.g005
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PLOS Pathogens | DOI:10.1371/journal.ppat.1006039 December 5, 2016 10 / 25
The CXCL12/CXCR4 Pathway in HPV Pathogenesis
PLOS Pathogens | DOI:10.1371/journal.ppat.1006039 December 5, 2016 11 / 25
β-arrestin-mediated signaling, lacks the ability to impair virus production, further supporting
the capacity of CXCR4 to tune the viral life cycle through its downstream signaling pathways.
Blockade of CXCR4 function diminishes oncogene expression
To further assess the role of CXCR4 activity in the HPV life cycle, CXCR4wt- and CXCR41013-
rafts were treated with AMD3100, a selective and competitive antagonist of CXCR4 [41] that
efficiently blocks CXCR41013 function [28]. The architecture and viral expression patterns of
raft cultures treated with AMD3100 were compared to control ones (untreated rafts) by immu-
nohistochemistry and western blot analyses (Fig 7). The stratified epithelium in CXCR4wt and
CXCR41013-rafts treated with AMD3100 was thinner than in untreated rafts (Fig 7, panel A)
but keratinocytes differentiation was apparently not affected given the normal expression pat-
tern for keratin 10 (S9 Fig panel A). E4 and L1 proteins were readily detected in the upper lay-
ers of CXCR41013-rafts treated with AMD3100 (Fig 7, panel B) as in CXCR4wt-rafts treated
with AMD3100 (S9 Fig panel B), while sparsely detected (L1) or undetectable (E4) in untreated
CXCR41013-raft cultures (Fig 7, panel B). In contrast, AMD3100 treatment reduced expression
of the E6 and E7 oncoproteins in CXCR41013- and CXCR4wt-rafts (Fig 7, panel C and D,
respectively). Thus blocking CXCR41013-dependent signaling allows virus production, while
reducing oncogene-expression and–driven neoplastic-like changes. Moreover, we found that
tumors produced by injecting CXCR41013-expressing human keratinocytes immortalized by
HPV18 [29] into nude mice were significantly smaller in AMD3100-treated mice than in
untreated mice (Fig 8). Collectively, these results indicate that CXCL12/CXCR4 signaling
impacts the balance between HPV replication and HPV-driven carcinogenesis.
Discussion
Considering the role of the CXCL12/CXCR4-signaling in the migration and survival of
HPV18-infected keratinocytes, we investigated the importance of this axis in the productive
HPV life cycle in which the timely and coordinated expression of different viral genes occurs
as infected cells move toward the epithelial surface where virions mature. In view of the conse-
quences of axis deregulation in HPV-induced cell transformation via the CXCR41013 gain-of-
function mutant, we investigated the impact of CXCR41013 expression on the productive HPV
life cycle in an organotypic model of human epidermis.
Our results demonstrate that unregulated CXCR41013 function fosters a keratinocyte envi-
ronment that restrains the productive HPV18 life cycle in contrast to CXCR4wt-expressing
rafts that efficiently reproduce the complete HPV life cycle including the production of infec-
tious virions. These findings in CXCR41013-rafts correlate with deregulated keratinocyte prolif-
eration and the stabilization of the E6 and E7 oncoproteins together with dramatic decreases
in production of the late viral proteins involved in HPV virion assembly. These results are
especially relevant because CXCL12 is expressed in keratinocytes from HPV-infected raft cul-
tures (S10 Fig). This extends previous studies detecting CXCL12 expression in epidermal kera-
tinocytes from HPV-induced lesions but not from other skin pathologies and normal skin [28,
Fig 6. Normalizing β-arrestin-dependent signaling of CXCR41013 partially restores the productive HPV
life cycle. (A) Western blots (left) and densitometric analyses (right) showing relative levels of HPV18-E2
protein in HPV18-positive CXCR4wt, CXCR41013, and CXCR41013&ΔSHSK raft cultures. E2 protein levels were
normalized to GAPDH protein levels and arbitrarily set at 1 for CXCR4wt rafts (staining controls are shown in
S5 Fig). Values are means ± SEM. **p < 0.01 and ***p < 0.001. HPV18-positive CXCR41013&ΔSHSK raft
sections stained for HPV18-E4 (B), HPV18-L1 (C), and Ki-67 (D) expression by immunohistochemical
staining. Images are representative of three independent experiments. Scale bars = 100 μm, inset scale
bar = 10 μm.
doi:10.1371/journal.ppat.1006039.g006
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Fig 7. Blocking CXCR41013 activity by the selective antagonist AMD3100 restores the productive HPV life cycle. (A) Sections
of HPV18-positive CXCR4wt and CXCR41013 raft cultures treated (AMD3100-treated) or not (untreated) with AMD3100 and stained
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42]. Thus collectively, our results support the concept that the CXCL12/CXCR4 pathway con-
trols the HPV productive life cycle, likely reflecting the normal function of this pathway as a
regulator of keratinocyte proliferation and survival. When deregulated, as in the WHIM syn-
drome, the CXCL12/CXCR4 pathway can trigger HPV-induced transformation as a result of
elevated levels of oncoprotein-induced signaling and down-regulation of DNA damage
response pathways associated with cell hyperproliferation.
On the one hand, the severe pathogenesis in WHIM patients manifests as intractable genital
warts that often develop into severe dysplasia and carcinoma [43, 44]. This pathogenesis is gen-
erally due to mucosal high-risk HPV types for which we can suggest that expression of
CXCR41013 might enhance transforming capacity, partly through the elevation of E6/E7 pro-
teins expression that drive proliferation of the infected cells, although this remains to be inves-
tigated directly in patients-derived cells. In some cases, patients’ dysplasia was found to be
associated with low-risk HPV types, such as HPV6, which display potential oncogenicity [45].
On the other hand, the profusion and persistency of cutaneous warts is another major clinical
manifestation of the WHIM-associated HPV pathogenesis. In this regard, it can be postulated
a role for CXCR41013 in driving the initial proliferation of the infected cells, thus allowing
expression and replication of cutaneous low-risk HPV types, which do not normally stimulate
proliferation. Our study is providing the rational for future mechanistic investigations of the
with hematoxylin and eosin. (B) Representative HPV18-positive CXCR41013 raft cultures sections treated or not with AMD3100 and
stained for HPV18-E4 (upper panel) or HPV18-L1 (lower panel). Images are representative of three independent experiments. Scale
bars = 100 μm, inset scale bar = 10 μm. Quantifications of E4- and L1-positive cells in untreated and AMD3100-treated (treated) rafts
from histological analyses are expressed as the percentage of positive cells out of the total number of epithelial cells. Values are
means ± SEM. (C-D) Western blots (left) and densitometric analyses (right) showing relative levels of HPV18-E6 and HPV18-E7
proteins in HPV18-positive CXCR41013 (C) and CXCR4wt (D) raft cultures treated or not with AMD3100. E6 and E7 protein levels
were normalized to GAPDH and arbitrarily set at 1 for untreated raft cultures. Values are means ± SEM. **p < 0.01 and ***p < 0.001.
doi:10.1371/journal.ppat.1006039.g007
Fig 8. AMD3100 treatment reduces the size of the tumors induced by injection of HPV18-positive keratinocytes expressing CXCR41013
in nude mice. Tumor growth curve of the average tumor volume (mm3 ± SEM) in each group (n = 6 for AMD3100-treated mice and n = 7 for PBS-
control mice) as a function of time. Representative results from one of two independent experiments are shown. **p < 0.01 (two-way ANOVA).
doi:10.1371/journal.ppat.1006039.g008
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productive life cycle of cutaneous low-risk HPV, which remains underappreciated due to the
lack of robust in vitro models.
We have found that CXCR41013 expression in keratinocyte raft cultures is associated with
the stabilization of the E6 and E7 oncoproteins. This was not associated with an integration of
the HPV genome further supporting that disruption of the E2 ORF is not the only mechanism
of suppressing E2 and increasing E6 and E7 expression as previously reported in HPV16-in-
duced carcinogenic progression [46]. Such modulations of oncoproteins expression might
involve the ubiquitin-proteasome system, which is involved in the degradation of E6 produced
by the high-risk types HPV18 and HPV16 [47]. Additionally, the capacity of E6 to interact
with certain PDZ domain proteins and phosphoserine-binding proteins involved in cell signal-
ing pathways is a mechanism for regulating E6 stability that is common to diverse high-risk
HPV types [48–50]. Beside PDZ domain proteins, chemokine receptors including CXCR4 can
interact with chaperone proteins, some being recently found to increase the steady-state levels
and half-life of E6 and E7 oncogenes [51, 52]. As the interaction of E6 with either of these pro-
tein families depends on its phospho-regulation by various kinases (e.g. protein kinase A or B)
and determines the fate of E6, different environmental conditions might have a significant
impact on the likelihood of HPV infection progressing toward malignancy [53]. We propose
that changes in cell signaling pathways in the context of CXCR41013 expression, and notably in
the downstream kinases activated by CXCL12-CXCR4 signaling may differentially affect the
stability of HPV18 E6. Some kinases, as well as the rate of ubiquitination, can also control the
steady-state level of E7 by interfering with proteasome-dependent degradation, but these pro-
cesses have been studied in the context of only a few HPV types (HPV16 and HPV6) [54, 55].
Increased production of E6 and E7 proteins in the context of CXCR41013 expression makes
rafts prone to drive the viral lifecycle toward carcinogenesis as demonstrated by the altered lev-
els of keratinocyte proliferation and apoptosis and by a disturbance in the ordered expression
of viral gene products that normally leads to virus replication and production. Whether the
fact that rafts derive from the spontaneously immortalized human NIKS keratinocytes might
contribute to this process is not known and is awaiting the setting of rafts from primary
human keratinocytes for HPV life cycle modeling.
Previous studies have clearly suggested that an increase in high-risk HPV protein levels can
drive a more severe neoplastic phenotype [56]. Among these viral proteins, we observed a dra-
matic decrease in the level of E2 that might be related to enhanced degradation by the ubiqui-
tin-proteasome system, which controls viral protein stability and was proposed to operate in
cycling cells [57]. Aberrant cell cycle progression in CXCR41013-rafts might thus increase E2
degradation and diminish its activity in the late phases of the viral life cycle. Conversely, nor-
malizing arrestin-dependent signaling downstream of CXCR41013 (CXCR41013&ΔSHSK) might
stabilize E2 protein thus partially restoring the productive HPV life cycle. This shift toward
viral production was revealed by the enhanced production of L1 and E4, which are primarily
involved in genome packaging and virus release [1, 58, 59]. The stabilization of E2 in
CXCR41013&ΔSHSK-rafts might also be accounted for the physical and functional interaction of
E2 and E4 as the level of each protein is increased by the presence of the other [60].
Additionally, and consistent with the recently reported essential role of DNA damage
responses in the viral replication [37], ATM/CHK pathway activation was found to be signifi-
cantly lower in CXCR41013-rafts. The contribution of ATM/CHK pathway activation to viral
replication has begun to be deciphered but its function in HPV-induced cancer development
remains unclear, especially because E7 and E6 have important roles in promoting this activa-
tion [38, 61]. Decreased activation of the ATM/CHK proteins in CXCR41013-rafts, in spite of
increased expression of E6 and E7, may appear paradoxical. However, such deregulation
might include the JAK/STAT pathway, which is induced downstream of CXCR4 in a G
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protein-independent manner [62] and was shown to activate the ATM-dependent DNA dam-
age responses [38]. Although the biological role of DNA damage responses in HPV-induced
malignancy is still uncertain, decreasing the production or activation of ATM/CHK proteins
would likely lead to the accumulation of DNA damage in CXCR41013-rafts.
In cervical disease, it is thought that the levels of E6 and E7 rise with cervical intraepithelial
neoplasia (CIN) severity. Changes in gene expression underlie the neoplastic progression, with
CIN1 lesions supporting the complete HPV life cycle in contrast to CIN3 lesions that are con-
sidered to be high-grade precancerous. We provide evidence that blocking CXCL12/
CXCR4-dependent signaling in the course of raft culture differentiation allowed the produc-
tive HPV life cycle to proceed at the expense of the HPV-induced carcinogenesis in
CXCR41013-rafts. These results provide molecular clues to the potential therapeutic effect of
AMD3100 treatment for skin warts when combined with imiquimod [63] but also for HPV-
induced carcinogenesis in a mouse preclinical model [64] and here in nude mice after injec-
tion of human keratinocytes immortalized by HPV18 and expressing CXCR41013. Whereas we
think that the interplay between the HPV life cycle and CXCL12/CXCR4 in keratinocytes is
the direct mediator element, the beneficial effect of AMD3100 might also be related to other
components that are controlled by this signaling axis (e.g. resident and infiltrating immune
cells in the skin, stem cell recruitment, or endothelial cell responses). The CXCL12/CXCR4
pair is indeed involved in the increased survival and/or proliferation of cancer cells from vari-
ous types including virus-related cancers, as well as in the promotion of tumor metastasis and
angiogenesis linked to tumor progression [65–69].
In light of the HPV-pathogenesis associated with the WHIM syndrome, it can be extrapo-
lated that dysfunction of CXCR4 might be acquired from genetic errors accumulated during
the multistep process of HPV-induced neoplasia, as demonstrated by the somatic WHIM-like
CXCR4 mutations reported in Waldenstro¨m macroglobulinemia [70] or the anomalies in the
effectors of the CXCL12/CXCR4-signaling pathway reported in patients with GATA2-defi-
ciency [71–73]. Clues to the additional effectors of this potentially pathogenic process arise
from the abnormal expression of CXCL12 in HPV-lesions in the general population of HPV
infected individuals [28] and from the presence of CXCL12 (our data) among the panel of
expressed genes unique to the discrete population of cuboidal cells located in the cervical squa-
mocolumnar junction, which have been linked to HPV-related cervical intraepithelial neopla-
sia and cancers [5]. Consequently, the CXCL12/CXCR4 signaling pathway appears to be an
important host factor in HPV-induced pathogenesis.
Materials and Methods
Routine cell culture
NIKS cells, near-diploid spontaneously immortalized human keratinocytes [31] (kindly pro-
vided by Dr Paul F. Lambert), were maintained at subconfluence on mitomycin C-treated
3T3-J2 feeder cells (kindly provided by Dr Paul F. Lambert) in F medium with all supplements
as previously described [30]. Human foreskin fibroblasts (kindly provided by Dr Paul F. Lam-
bert) were cultured in Ham’s F12 medium containing 10% fetal bovine serum and 1% penicil-
lin-streptomycin, before use in raft cultures.
Generation of HPV18-positive NIKS cells expressing CXCR4-derived
receptors
NIKS cells expressing CXCR4wt, CXCR41013 or CXCR41013&ΔSHSK were obtained with a lentivi-
rus-mediated strategy as previously described [29, 39]. Expression of similar levels of each
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receptor in the different cell populations was checked by flow cytometry (S1 Fig, panel B).
Recircularized HPV18 DNA was prepared as previously described [30]. The different NIKS
cell populations (2.5 x 106 cells plated the day before the transfection) were cotransfected with
2 μg of recircularized HPV18 DNA and 0.5 μg of the blasticidin-resistance plasmid pcDNA6
using Effectene Transfection Reagent (QIAGEN). Blasticidin selection (7 μg/mL) was per-
formed for 6 days.
Organotypic raft cultures
HPV18-positive NIKS cells expressing CXCR4wt, CXCR41013, or CXCR41013&ΔSHSK were
grown in raft cultures to induce the three-dimensional architecture of the stratified epithelium,
as described previously [30]. Briefly, 1.5 x 106 NIKS cells were seeded onto a dermal equivalent
composed of rat-tail collagen type 1 containing 1 x 106 human foreskin fibroblasts. Raft cul-
tures were lifted onto transwell inserts submerged in deep well plates containing keratinocyte
plating medium and cultured for 4 days. The transwell inserts were then raised by placing four
cotton pads underneath them, thereby exposing the epithelial cells to the air-liquid interface.
Raft cultures were fed by diffusion from below with cornification medium and were allowed to
stratify for 14 days. When specified, AMD3100 (A5602, Sigma-Aldrich) was added to the cor-
nification medium at a concentration of 20 μg/mL from day 4 to the end of the experiment.
Rafts were then removed from transwell inserts and either fixed in formalin and embedded in
paraffin for histological analyses, or frozen at −80˚C for quantitative real-time PCR and west-
ern blot analyses.
Calcium-induced differentiation
To induce differentiation in medium containing 1.5 mM CaCl2 (high calcium), HPV18-posi-
tive NIKS cells expressing either CXCR4wt or CXCR41013 were cultured in absence of 3T3-J2
feeders in F medium for 24 h and then switched to F medium (without growth supplements)
containing 1.5 mM CaCl2. Cells were then harvested at 0, 48, and 96 hours for protein
extraction.
Western blot analysis
NIKS cells from monolayer cultures or rafts cultures were resuspended in protein lysis buffer
(1% Triton X-100, 10 mM Tris-HCl pH 7.4, supplemented with Protease and Phosphatase
Inhibitor Tablets (Pierce)). Protein concentration was measured with the BCA Protein Assay
Kit (Pierce) according to the manufacturer’s protocol. Equivalent amounts of protein were
separated on a SDS-polyacrylamide gel and transferred to a PVDF membrane. Primary
antibodies were as follows: anti-HPV18-E6 (kindly provided by Arbor Vita Corporation),
anti-HPV18-E7 (sc-1590, Santa Cruz), anti-HPV18-E2 (kindly provided by Dr. F. Thierry),
anti-p53 (sc-126, Santa Cruz), anti-involucrin (I9018, Sigma-Aldrich), anti-GAPDH (14–9523,
eBioscience); anti-pATM (Ser1981; #13050), anti-ATM (#2873), and anti-pCHK2 (Thr68) and
anti-CHK2 (#2661 and #3440, respectively, Cell Signaling). Membranes were incubated with
the appropriate secondary antibodies conjugated to HRP (GE Healthcare). Proteins were
detected using the Immobilon Western Chemiluminescent HRP kit (Millipore).
Histological analysis
Raft paraffin sections (5-μm thick) were stained with hematoxylin and eosin (HE), and with
safran (HES) where indicated. Immunohistochemistry was performed on paraffin sections
using primary antibodies for keratin 10 (MA1-35540, Thermo Scientific), filaggrin (VP-F706,
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Vector laboratories), HPV18-E2 (provided by Dr. F. Thierry), HPV18-E4 (provided by Dr. J.
Doorbar), HPV18-L1, p16 (sc-56330, Santa Cruz), Ki-67 (18-0191Z, AbCys), and CXCL12
(K15C clone, MABC184, EMD Millipore). Bound antibodies were detected using the LSAB
+/HRP kit (K0679, Dako) or the AEC+ High Sensitivity Substrate Chromogen Ready-to-Use
System (K3461, Dako). For immunofluorescence, staining with the primary antibody for
MCM2 (ab31159, Abcam) was followed by staining with a goat anti-rabbit Alexa Fluor 596
(Invitrogen). Tissues were counterstained with DAPI. For the TUNEL assay to detect apopto-
tic cells, we used the In Situ Cell Death Detection Kit, Fluorescein (11684795910, Roche Diag-
nostics) according to the manufacturer’s instructions. In situ hybridization was performed
with the wide spectrum HPV biotinylated DNA probe sets able to detect 11 types of anogenital
HPV (In Situ Hybridization Detection System, K0601, Dako).
Image analysis
Where indicated, slides were scanned by the digital slide scanner NanoZoomer 2.0-RS (Hama-
matsu) allowing an overall view of the samples. Images were digitally captured from the
scanned slides using the NDP.view2 software (Hamamatsu). All quantifications from the his-
tological analyses were performed by counting 10 different fields on the scanned slides. Other
slides were analyzed using a Leica DMLA microscope, in particular to visualize images at 100X
magnification, and images were captured with a Leica DFC450 C digital microscope camera.
Immunochemical stainings were interpreted simultaneously and independently by at least two
investigators (FM, LC, or FG).
Nude mice xenografts and AMD3100 treatment
HK-HPV18-CXCR41013 tumors were established in nude mice as previously described [29].
Briefly, athymic female nude nu/nu 5-week-old mice (Harlan Laboratories) were injected sub-
cutaneously with 2 x 107 HK-HPV18 cells expressing T7-GFP-tagged CXCR41013 in the right
flank (six to seven mice per group). Mice were treated with 5 mg/kg of AMD3100 (intraperito-
neal administration) on days 8, 13, 16, and 20 after tumor cell injection. Tumor volumes (V)
were calculated as V = π/6 x (length x width2).
Ethics Statement
All experimental procedures were conducted in our animal facility (agreement n˚ B 92-023-
01) in accordance with the European Union’s legislation and the relevant national legislation,
namely the French “De´cret no 2013–118, 1er fe´vrier 2013, Ministère de l’Agriculture, de
l’Agroalimentaire et de la Forêt” regarding the use of laboratory animals and were approved by
the Committee on the Ethics of Animal Experiments (Comite´ d’Ethique en Expe´rimentation
Animale Capsud or CEEA-26) under the authorization 2014_039 #2521.
Statistical analysis
Student’s t test was used to compare the significance between specified groups. All analyses
were performed with GraphPad Prism software.
Supporting Information
S1 Fig. Expression of CXCR4 receptors in HPV18-positive keratinocyte NIKS cell lines in
monolayer and raft cultures. (A) Cell surface expression of CXCR4 in CHO cells transfected
with 1 and 2.5 μg of a vector encoding for the human CXCR4 receptor was investigated by
flow cytometry using the 12G5 antibody, which specifically recognizes the human form of
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CXCR4 and not the endogenous Chinese hamster CXCR4 receptor. (B) Cell surface expression
of CXCR4 in HPV18-positive NIKS cells, non-transduced (i.e. endogenous (Endo.) CXCR4)
as compared to cells transduced with lentiviral vectors expressing CXCR4wt or CXCR41013 (left
graph) or to uninfected NIKS cells (right graph). Cell surface expression of CXCR4, investi-
gated by flow cytometry using the 12G5 antibody, is represented as mean fluorescence inten-
sity (MFI) ± SEM (n = 3). (C) HPV18-positive NIKS cells non-transduced (i.e. endogenous
CXCR4) or transduced with lentiviral vectors expressing CXCR4wt or CXCR41013 were investi-
gated for CXCR4 transcripts levels. Transcripts were expressed as relative levels normalized to
GAPDH transcripts levels (mean ± SEM, n = 3). (D) Detection of CXCR4 expression by
immunofluorescence in HPV18-positive raft cultures sections (i.e. endogenous CXCR4) and
in HPV18-positive CXCR4wt and CXCR41013 raft culture sections. Images are representative of
three independent experiments. Scale bars = 100 μm, inset scale bars = 20 μm.
(TIF)
S2 Fig. Viral DNA and transcripts in CXCR4wt and CXCR41013 NIKS cells in monolayer
and in raft cultures. (A) HPV18-positive NIKS cells non-transduced (i.e. endogenous
CXCR4) or transduced with lentiviral vectors expressing CXCR4wt or CXCR41013 were investi-
gated for HPV18 DNA copy numbers before (i.e. HPV18-infected NIKS) and after being dif-
ferentiated into 3D cultures (i.e. HPV18-infected rafts). Uninfected rafts were also integrated
as negative control. HPV18 DNA copy numbers are expressed as the ratio to GAPDH gene
copy numbers (mean ± SEM, n = 3). (B) HPV18-E6/E7 and HPV18-E2 transcripts levels in
HPV18-positive CXCR4wt and CXCR41013 NIKS cells cultured in monolayers before being dif-
ferentiated into raft cultures (see S6 Fig). Transcripts were expressed as relative levels normal-
ized to GAPDH transcripts levels (mean ± SEM, n = 3).
(TIF)
S3 Fig. Architecture of HPV18-positive raft cultures developed from keratinocytes
expressing endogenous CXCR4 only. Representative section of HPV18-positive raft cultures
stained with hematoxylin and eosin (HE; upper panel) and for HPV18-E4 protein (lower
panel). Images are representative of three independent experiments. Scale bars = 100 μm.
(TIF)
S4 Fig. Analysis of infectious virus progeny. HaCat cells were infected with a 1:20 or 1:100
dilution of viral stocks harvested from either HPV18-positive CXCR4wt or CXCR41013 raft cul-
tures. Shown is a 2% agarose gel of nested RT-PCR-amplified β-actin and HPV18 E1^E4. Lane
1, CXCR4wt HPV18 at 1:20. Lane 2, CXCR4wt HPV18 at 1:100. Lane 3, CXCR41013 HPV18 at
1:20. Lane 4, CXCR41013 HPV18 at 1:100. Lane 5, negative control (no virus). β-actin and
HPV18 E1^E4 sequences were confirmed by sequencing and positions are indicated in the
right and molecular size markers are indicated in the left.
(TIF)
S5 Fig. Control experiments for E2, E6 and E7 antibodies specificity. Western blots showing
detection of HPV18-E2, HPV18-E6 and HPV18-E7 proteins in uninfected (negative control
for the detection of HPV18 proteins) versus HPV18-infected conditions (rafts or NIKS cells).
Proteins were extracted from raft cultures (left panel) or NIKS cells (central and right panels).
GAPDH detection and size markers are also shown.
(TIF)
S6 Fig. Virus transcription and integration in HPV18-positive raft cultures and LCR activ-
ity in NIKS cells. HPV18-positive CXCR4wt and CXCR41013 raft cultures were investigated
(A) for HPV18-E6/E7 and HPV18-E2 transcripts levels (transcripts were expressed as relative
The CXCL12/CXCR4 Pathway in HPV Pathogenesis
PLOS Pathogens | DOI:10.1371/journal.ppat.1006039 December 5, 2016 19 / 25
levels normalized to GAPDH transcripts levels (mean ± SEM, n = 3)), and (B) for HPV inte-
gration using the APOT assay. Shown is a 1.2% agarose gel of nested RT-PCR-amplified HPV
E7. Lane 1, negative control (HaCat cells); lanes 2 and 3, positive controls (Human keratino-
cytes and HeLa cells, respectively, containing integrated HPV18 genome); lanes 4 to 6,
HPV18-infected NIKS, CXCR4wt NIKS and CXCR41013 NIKS, respectively; lanes 7 and 10,
HPV18 infected NIKS-derived rafts; lanes 8 and 11, CXCR4wt-rafts; Lanes 9 and 12,
CXCR41013-rafts. Molecular size markers are indicated in the right and positive controls in
lanes 2 and 3 were confirmed by sequencing. (C) Luciferase reporter assays was used to investi-
gate the intrinsic promoter activity of the HPV18 LCR in NIKS cells transduced for expression
of CXCR4wt or CXCR41013, and transiently transfected with the LCR-HPV18-luciferase vector.
Luciferase ratio represents the fold increase of luciferase signal over the luciferase activity in
cells transfected with the control pClucF plasmid (mean ± SEM, n = 3).
(TIF)
S7 Fig. CXCR41013-mediated transforming properties involved stabilization of the E6 and
E7 HPV oncoproteins in NIKS cells. Western blots (upper panels) and densitometric analyses
(lower panels) showing relative levels of HPV18-E6 and HPV18-E7 in HPV18-positive
CXCR4wt and CXCR41013 NIKS cells differentiated in high-calcium media for 96 h (A) or
undifferentiated (B). NIKS cells were treated with cycloheximide (50 μg/mL) for the indicated
times. Densitometric analyses represent E6 and E7 protein levels normalized to GAPDH pro-
tein levels and expressed as percent of the initial levels at time 0 set at 100%. (A) E6 protein lev-
els were 0.19 +/- 0.01; 0.14 +/- 0.01; 0.086 +/- 0.008 and 0.25 +/- 0.01; 0.167 +/- 0.01; 0.168 +/-
0.01 (at 0, 1 and 2 h post cycloheximide for CXCR4wt and CXCR41013, respectively). E7 protein
levels were 2.0 +/- 0.12; 2.13 +/- 0.10; 1.34 +/- 0.16; 0.44 +/- 0.01 and 1.18 +/- 0.029; 1.34 +/-
0.019; 1.23 +/- 0.023; 0.79 +/- 0.03 (0, 1, 2 and 4 h post cycloheximide for CXCR4wt and
CXCR41013, respectively). (B) E6 protein levels were 0.56 +/- 0.10; 0.48 +/- 0.10; 0.41 +/- 0.10;
0.30 +/- 0.09 and 0.76 +/- 0.09; 0.71 +/- 0.11; 0.64 +/- 0.10; 0.43 +/- 0.11 (0, 1, 2 and 4 h post
cycloheximide for CXCR4wt and CXCR41013, respectively). E7 protein levels were 0.3 +/- 0.08;
0.24 +/- 0.07; 0.19 +/- 0.07; 0.17 +/- 0.06 and 0.42 +/- 0.09; 0.38 +/- 0.10; 0.32 +/- 0.09; 0.27 +/-
0.09 (0, 1, 2 and 4 h post cycloheximide for CXCR4wt and CXCR41013, respectively). Values are
the mean ± SEM. p< 0.01 and p< 0.001.
(TIF)
S8 Fig. Architecture of HPV-negative raft cultures. Representative sections of HPV-negative
(HPV-) CXCR4wt and CXCR41013 raft cultures stained with hematoxylin and eosin (HE; upper
panel), or for Ki-67 or keratin 10 expression (middle and lower panel, respectively). Images
are representative of three independent experiments. Scale bars = 100 μm.
(TIF)
S9 Fig. Keratin 10 and HPV18-E4 expression in raft cultures treated with AMD3100. Rep-
resentative sections of HPV18-positive CXCR4wt and CXCR41013 raft cultures treated
(AMD3100-treated) or not (untreated) with AMD3100 were investigated (A) for keratin 10,
and (B) for HPV18-E4 expression. Images are representative of three independent experi-
ments. Scale bars = 100 μm (A) and as shown (B).
(TIF)
S10 Fig. CXCL12 expression in epidermal keratinocytes from HPV18-positive raft cul-
tures. Representative sections of HPV18-positive CXCR4wt and CXCR41013 raft cultures
stained for CXCL12 protein. Immunohistochemistry was performed using primary antibody
for CXCL12.
(TIF)
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S1 Protocol.
1. HPV detection by quantitative real-time PCR analysis
2. Luciferase assay
3. APOT assay
4. Virus isolation and in vitro infectivity essay
5. Expression of CXCR4 by flow cytometry, quantitative real-time PCR and immunofluores-
cence
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